Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,745 | 84 | 99.0% |
| Education | $18.08 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $613.31 | 33 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $521.99 | 8 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $176.54 | 18 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $105.21 | 1 | $0 (2024) |
| PFIZER INC. | $95.75 | 8 | $0 (2021) |
| Genentech USA, Inc. | $35.45 | 3 | $0 (2018) |
| Inspire Medical Systems, Inc. | $33.21 | 2 | $0 (2024) |
| Octapharma USA, Inc. | $24.05 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $23.76 | 2 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $21.76 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.20 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($105.21) |
| 2023 | $63.93 | 4 | GlaxoSmithKline, LLC. ($47.79) |
| 2022 | $79.64 | 5 | GlaxoSmithKline, LLC. ($61.15) |
| 2021 | $295.83 | 16 | GlaxoSmithKline, LLC. ($176.45) |
| 2020 | $84.37 | 6 | GlaxoSmithKline, LLC. ($65.70) |
| 2019 | $204.11 | 10 | GlaxoSmithKline, LLC. ($192.49) |
| 2018 | $531.02 | 24 | Actelion Pharmaceuticals US, Inc. ($319.36) |
| 2017 | $328.74 | 15 | Actelion Pharmaceuticals US, Inc. ($202.63) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $105.21 | General |
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Respiratory | ||||||
| 06/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROLOGY | ||||||
| 11/29/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROLOGY | ||||||
| 02/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2022 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/16/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.03 | General |
| Category: Cardiovascular | ||||||
| 08/10/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/04/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/21/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/16/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/30/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $18.08 | General |
| Category: PAH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 628 | 1,024 | $186,744 | $82,563 |
| 2022 | 16 | 649 | 1,065 | $197,363 | $82,079 |
| 2021 | 16 | 795 | 1,321 | $235,102 | $109,642 |
| 2020 | 19 | 908 | 1,466 | $250,063 | $114,698 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 263 | $53,652 | $23,526 | 43.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 57 | 145 | $49,300 | $22,821 | 46.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 190 | $24,700 | $11,489 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 110 | $17,600 | $9,649 | 54.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 43 | $11,610 | $5,695 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 67 | $8,710 | $4,130 | 47.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 27 | 30 | $2,850 | $1,163 | 40.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,275 | $1,097 | 48.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 22 | 25 | $2,375 | $868.34 | 36.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 20 | 22 | $6,600 | $547.76 | 8.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 18 | 19 | $3,325 | $506.34 | 15.2% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 14 | 16 | $1,456 | $393.26 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $314.93 | 81.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 33 | $396.00 | $277.20 | 70.0% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 23 | 25 | $250.00 | $58.00 | 23.2% |
| 94761 | Test to measure oxygen level in blood using ear or finger device multiple times | Office | 2023 | 12 | 12 | $1,260 | $28.11 | 2.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 61 | 185 | $62,760 | $30,617 | 48.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 134 | 320 | $65,280 | $24,734 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 69 | $11,040 | $6,097 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 102 | $13,350 | $5,946 | 44.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 37 | $9,990 | $5,676 | 56.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 67 | $8,710 | $3,705 | 42.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 30 | 35 | $3,225 | $1,323 | 41.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 27 | 32 | $2,865 | $1,077 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,925 | $934.36 | 48.5% |
About Dr. Ruxandra Ionescu, MD
Dr. Ruxandra Ionescu, MD is a Critical Care Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093905408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruxandra Ionescu, MD has received a total of $1,763 in payments from pharmaceutical and medical device companies, with $175.20 received in 2024. These payments were reported across 85 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,745).
As a Medicare-enrolled provider, Ionescu has provided services to 2,980 Medicare beneficiaries, totaling 4,876 services with total Medicare billing of $388,982. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Greenwood, IN
- Active Since 08/01/2007
- Last Updated 01/13/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1093905408
Products in Payments
- OPSUMIT MACITENTAN (Drug) $521.99
- NUCALA (Biological) $396.39
- TRELEGY ELLIPTA (Drug) $204.38
- LONHALA MAGNAIR (Drug) $87.79
- ELIQUIS (Drug) $73.47
- Utibron (Drug) $36.92
- CHANTIX (Drug) $35.31
- UTIBRON (Drug) $33.87
- INSPIRE (Device) $33.21
- Xolair (Biological) $24.65
- CUTAQUIG (Biological) $24.05
- QVAR (Drug) $21.76
- DUPIXENT (Biological) $18.67
- KENGREAL (Drug) $18.49
- TYVASO (Drug) $18.08
- BROVANA (Drug) $17.96
- BREZTRI (Drug) $15.50
- ANORO ELLIPTA (Drug) $12.54
- SAMSCA (Drug) $12.31
- RECARBRIO (Drug) $12.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenwood
Dr. Sandeep Kukreja, M.d, M.D
Critical Care Medicine — Payments: $358,561
Dr. Faisal Khan, Md, MD
Critical Care Medicine — Payments: $169,121
Dr. Imad Shawa, Md, MD
Critical Care Medicine — Payments: $28,103
Dr. Aaron Bruns, M.d, M.D
Critical Care Medicine — Payments: $4,727
Dr. Winston Nara, Md, MD
Critical Care Medicine — Payments: $3,963
Melinda Quarles, Msn, Rn, MSN, RN
Critical Care Medicine — Payments: $368.07